The QUVIVIQ®
Pregnancy Registry

for women diagnosed with insomnia who have (or have not) taken QUVIVIQ® (daridorexant) during or shortly before their pregnancy.

Are you pregnant? Did you have insomnia (difficulty sleeping) before you were pregnant?
Are you interested in helping to add to our knowledge about sleep medications and pregnancy?
Take part in our observational registry, which aims to learn more about the health of pregnant women with insomnia and the health of their babies.

About the Registry

The QUVIVIQ Pregnancy Registry is for women diagnosed with insomnia who have (or have not) taken QUVIVIQ® (daridorexant) during or shortly before their pregnancy.

Women who had insomnia before becoming pregnant and who took other sleep medications, or no sleep medications, may also be able to take part.

Researchers will review the results of each group and compare any effects QUVIVIQ has on:

mothers,
pregnancies, and
unborn babies and infants.

This study has been reviewed by an Institutional Review Board (IRB)/Ethics Committee (EC), which protects the rights, safety, and well-being of participants.

Who can take part?

You, or someone you know, may be able to take part if you/they:

are pregnant
have been diagnosed with insomnia.

If you are currently pregnant, you do not need to have taken insomnia medication to join. Women who are no longer pregnant but who took QUVIVIQ during or shortly before their pregnancy can also take part.

Why participate?

Sleep loss has been associated with possible effects during pregnancy, such as low birth weight babies. However, it is not known whether QUVIVIQ, used to treat insomnia, will harm unborn babies.

This study may provide information about QUVIVIQ use during pregnancy and help pregnant women with insomnia in the future.

Learn more